Sabby Management’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
Other funds holding FOLD
PA
ACA
RG
Sabby Management's FOLD Position: Q4 2018 in Review
Sabby Management sold out of Amicus Therapeutics (FOLD) in Q4 2018, closing a stake of 155,044 shares — an estimated $1.87M sold.
Sabby Management first reported a position in FOLD in Q2 2014 and held it in 9 quarters. The position peaked at $1.87M in Q3 2018. 195 funds tracked by Wall St. Rank hold FOLD as of Q4 2018.
- Sabby Management reported no remaining Amicus Therapeutics position as of Q4 2018 after selling out during the quarter.
- Sabby Management sold 155,044 Amicus Therapeutics shares in Q4 2018, an estimated $1.87M.
- Sabby Management first reported a position in Amicus Therapeutics in Q2 2014 and held it in 9 quarters.
- Sabby Management's Amicus Therapeutics position peaked at $1.87M in Q3 2018.
- 195 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2018.
Based on Sabby Management's 13F filing for Q4 2018, filed 14 Feb 2019.